Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine
| Errataetall: |
CommentOn: Dermatol Online J. 2021 Jan 15;27(1):. - PMID 33560802 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
Therapie - 76(2021), 4 vom: 25. Juli, Seite 364-365 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19 |
|---|
| Beteiligte Personen: |
Bekkali, Nihal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Éruption éczematiforme |
|---|
| Anmerkungen: |
Date Completed 05.08.2021 Date Revised 05.08.2021 published: Print-Electronic CommentOn: Dermatol Online J. 2021 Jan 15;27(1):. - PMID 33560802 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.therap.2021.04.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328174696 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328174696 | ||
| 003 | DE-627 | ||
| 005 | 20231225202406.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.therap.2021.04.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1093.xml |
| 035 | |a (DE-627)NLM328174696 | ||
| 035 | |a (NLM)34272069 | ||
| 035 | |a (PII)S0040-5957(21)00108-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Bekkali, Nihal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine |
| 246 | 3 | 3 | |a Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.08.2021 | ||
| 500 | |a Date Revised 05.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Dermatol Online J. 2021 Jan 15;27(1):. - PMID 33560802 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a ARN messager | |
| 650 | 4 | |a Adverse event | |
| 650 | 4 | |a COVID19 | |
| 650 | 4 | |a Eczematiform eruption | |
| 650 | 4 | |a Effet secondaire | |
| 650 | 4 | |a Vaccin | |
| 650 | 4 | |a Vaccine | |
| 650 | 4 | |a mRNA | |
| 650 | 4 | |a Éruption éczematiforme | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Allard, Tanguy |e verfasserin |4 aut | |
| 700 | 1 | |a Lengellé, Céline |e verfasserin |4 aut | |
| 700 | 1 | |a Estève, Eric |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapie |d 1947 |g 76(2021), 4 vom: 25. Juli, Seite 364-365 |w (DE-627)NLM000023655 |x 1958-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2021 |g number:4 |g day:25 |g month:07 |g pages:364-365 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.therap.2021.04.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2021 |e 4 |b 25 |c 07 |h 364-365 | ||